BIAF
bioAffinity Technologies, Inc. · Services · Market cap $3.4M
Insiders sold $135K net in the last 90 days ·1 seller, 1 buyer· latest Form 4 filed Nov 19, 2026
Insider Buying
$1.0M
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Nov 19, 2026
HRT FINANCIAL LP
bioAffinity Technologies, Inc. (BIAF) has 1 SEC Form 4 filing (22 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Nov 19, 2026.
Inside the rolling window, 1 insider at bioAffinity Technologies, Inc. reported 8 open-market purchases totaling $1.0M and 8 open-market sales totaling $1.2M. The most active filer is 10% Owner HRT FINANCIAL LP with 16 filings. Insiders have net sold $135K over the trailing 6 months. The most recent open-market filing is a purchase of 18,929 shares by 10% Owner HRT FINANCIAL LP, dated Sep 22, 2026, worth $163K.
- Industry:Medical - Diagnostics & Research
- CEO:Maria Zannes
- Employees:57
- HQ:San Antonio, TX, US
- IPO:2022-09-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 18,929 | $163K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 7,077 | $61K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Purchase | 18,511 | $149K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 21,988 | $176K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Purchase | 30,065 | $231K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 27,246 | $211K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Purchase | 7,271 | $57K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 9,111 | $72K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Purchase | 10,736 | $82K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 14,008 | $106K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Purchase | 22,734 | $160K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 20,828 | $143K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Purchase | 12,125 | $82K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 20,432 | $138K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Purchase | 17,873 | $117K | Nov 19 | — | SEC ↗ | |
| 10% Owner | Sale | 41,529 | $268K | Nov 19 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does BIAF have?
bioAffinity Technologies, Inc. (BIAF) has 1 SEC Form 4 filing (22 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Nov 19, 2026.
When was the most recent SEC Form 4 filing for BIAF?
The most recent Form 4 filing for BIAF on Tracefour is dated Nov 19, 2026.
Who is the most active insider at BIAF?
The most active SEC Form 4 filer at BIAF in the rolling window is 10% Owner HRT FINANCIAL LP, with 16 filings.
What is the net insider flow at BIAF over the last 6 months?
Over the trailing 180 days, insiders at BIAF have net sold $135K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at BIAF in the current window?
Inside the rolling window, insiders at BIAF bought $1.0M and sold $1.2M based on SEC Form 4 filings.
Can I get alerts for BIAF insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at bioAffinity Technologies, Inc. (BIAF). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
bioAffinity Technologies, Inc. is in the Services sector.